CivicScience data show the majority (76%) of GLP-1 users intend to purchase clothing in the next three months
Most logged side effects Side effects are logged separately from overall experience
Auto-injectors, for example, offer an administration route that some patients may prefer over traditional syringe injections
Medication coverage varies greatly between different plans, provinces, and has specific criteria that determine eligibility
Retatrutide simultaneously activates GLP-1, GIP, and glucagon receptors, distinguishing it from approved single or dual agonists such as semaglutide and tirzepatide
Multi-agonist therapies combining GLP-1 with GIP or glucagon may amplify these benefits by improving fat metabolism and reducing cardiovascular risk even further